Given that CD36-mediated clearance of amyloid-β and myelin debris by macrophages is neuroprotective in AD and MS, respectively, CD36 S-palmitoylation may limit disease progression in these disorders. This evidence concerns the gene CD36 and myeloid sarcoma.